Key result
The novel ECHO pSAX method closely agreed with the gold standard Cardiac Magnetic Resonance for assessing left ventricular ejection fraction in infarcted mice, with a mean difference of -0.3%.
Why the study?
Although echocardiography has been proposed as an alternative to CMR for LV function assessment in small rodents, it may underestimate LV volumes when marked eccentric remodeling is present.
Does the ECHO pSAX method accurately agree with CMR for assessing left ventricular function in mice with myocardial infarction?
Does the ECHO pSAX method accurately agree with CMR for assessing left ventricular function in mice with myocardial infarction?
ECHO pSAX is a fast, inexpensive, and accurate alternative to CMR for assessing left ventricular volumes and ejection fraction in mice with myocardial infarction.
May support faster, cheaper LVEF assessment in mouse MI models; leaves open translation to other species and clinical use.
Cardiac Magnetic Resonance (CMR) is the gold standard for left ventricular (LV) function assessment in small rodents and, though echocardiography (ECHO) has been proposed as an alternative method, LV volumes may be underestimated when marked eccentric remodeling is present. In the present study we described a novel echocardiographic method and we tested the agreement with CMR for LV volumes and ejection fraction calculation in mice with experimental myocardial infarction. Sham-operated and infarcted mice, subjected to Coronary Artery Ligation, underwent ECHO and CMR. Volumes and ejection fraction were calculated by ECHO using a standard Simpson's modified method (ECHO pLAX) or a method from sequential parasternal short axis (ECHO pSAX) acquired mechanically by translating the probe every 1 mm along the left ventricle. The mean differences ±1.96 standard deviation near to zero suggested close agreement between ECHO pSAX and CMR; contrarily ECHO pLAX agreement with CMR was lower. In addition, ECHO was three times shorter and cheaper (Relative cost difference: pLAX: -66% and pSAX -57%) than CMR. In conclusion, ECHO pSAX is a new, fast, cheap and accurate method for LV function assessment in mice.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2019) studied Myocardial infarction (n=34). ECHO pSAX vs. Cardiac Magnetic Resonance (CMR) was evaluated on Mean difference in Left Ventricular Ejection Fraction (LVEF) between ECHO pSAX and CMR in infarcted mice. The novel ECHO pSAX method closely agreed with the gold standard Cardiac Magnetic Resonance for assessing left ventricular ejection fraction in infarcted mice, with a mean difference of -0.3%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: